Ignite Creation Date:
2024-05-06 @ 2:18 PM
Last Modification Date:
2024-10-26 @ 1:28 PM
Study NCT ID:
NCT04275323
Status:
COMPLETED
Last Update Posted:
2022-03-31
First Post:
2020-01-18
Brief Title:
Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia NL003-CLI-III-1
Sponsor:
Beijing Northland Biotech Co Ltd
Organization:
Beijing Northland Biotech Co Ltd
Organization Data
Organization:
Beijing Northland Biotech Co Ltd
Class:
INDUSTRY
Study ID:
NL003-CLI-III-1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Beijing Northland Biotech Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None